- Report
- January 2026
- 371 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 463 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 475 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 364 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 372 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 274 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 393 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 367 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 377 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 384 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 384 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 476 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 376 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 386 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 386 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 480 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 489 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 483 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 361 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 381 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more